Chinese-biotech company HitGen has signed an agreement with Danish pharmaceutical company LEO Pharma to use its advanced technology platform to discover new small molecules.
The molecules will be licensed to LEO Pharma and used for multiple therapeutic targets. HitGen will receive an initial upfront payment as well as milestone-based payments from LEO Pharma.
Go deeper with GlobalData
US-based pharmaceutical company Calithera Biosciences plans to raise gross proceeds of $250m through an offering of shares of its common stock.
Calithera plans to use the funds towards working capital and general corporate purposes.
Esperion Therapeutics plans for a public offering of common stock shares to raise up to $150m.
See Also:
The US-based pharmaceutical company plans to use the funds to progress its CLEAR Outcomes CVOT clinical trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataUS-based biopharmaceutical company Dynavax Technologies plans for a public offering of shares of its common stock to raise up to $125m.
The company plans to use the funds towards the commercial launch of HEPLISAV-B.
